C137H153F5N26O16 — CID 157479006
6-[2-[(3S)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;6-[2-(4-acetylpiperazin-1-yl)pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-(1-hydroxy-2-methylpropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one (PubChem CID 157479006) has the molecular formula C137H153F5N26O16 and a molecular weight of 2514.89 g/mol. Its IUPAC name is 6-[2-[(3S)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;6-[2-(4-acetylpiperazin-1-yl)pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-(1-hydroxy-2-methylpropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one.
| Compound Name | 6-[2-[(3S)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;6-[2-(4-acetylpiperazin-1-yl)pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-(1-hydroxy-2-methylpropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one |
|---|---|
| PubChem CID | 157479006 |
| Molecular Formula | C137H153F5N26O16 |
| Molecular Weight | 2514.89 g/mol |
| Exact Mass | 2513.19 |
| IUPAC Name | 6-[2-[(3S)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;6-[2-(4-acetylpiperazin-1-yl)pyrimidin-5-yl]-1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-(1-hydroxy-2-methylpropan-2-yl)pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)-5-methylphenyl]methyl]-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one |
| SMILES | CC(=O)N1CCN(c2ncc(-c3ccc4c(=O)n(C)n(Cc5cc(C)ccc5OC(C)F)c4c3)cn2)CC1.CC(=O)N1CCN(c2ncc(-c3ccc4c(=O)n(C)n(Cc5cc(C)ccc5OC(C)F)c4c3)cn2)C[C@H]1CO.Cc1ccc(OC(C)F)c(Cn2c3cc(-c4cnc(C(C)(C)CO)nc4)ccc3c(=O)n2C)c1.Cc1ccc(OC(C)F)c(Cn2c3cc(-c4cnc(N5CCC[C@@H]5CO)nc4)ccc3c(=O)n2C)c1.Cc1ccc(OC(C)F)c(Cn2c3cc(-c4cnc(N5CCC[C@H]5CO)nc4)ccc3c(=O)n2C)c1 |
| InChI | InChI=1S/C29H33FN6O4.C28H31FN6O3.2C27H30FN5O3.C26H29FN4O3/c1-18-5-8-27(40-19(2)30)22(11-18)15-36-26-12-21(6-7-25(26)28(39)33(36)4)23-13-31-29(32-14-23)34-9-10-35(20(3)38)24(16-34)17-37;1-18-5-8-26(38-19(2)29)22(13-18)17-35-25-14-21(6-7-24(25)27(37)32(35)4)23-15-30-28(31-16-23)34-11-9-33(10-12-34)20(3)36;2*1-17-6-9-25(36-18(2)28)20(11-17)15-33-24-12-19(7-8-23(24)26(35)31(33)3)21-13-29-27(30-14-21)32-10-4-5-22(32)16-34;1-16-6-9-23(34-17(2)27)19(10-16)14-31-22-11-18(7-8-21(22)24(33)30(31)5)20-12-28-25(29-13-20)26(3,4)15-32/h5-8,11-14,19,24,37H,9-10,15-17H2,1-4H3;5-8,13-16,19H,9-12,17H2,1-4H3;2*6-9,11-14,18,22,34H,4-5,10,15-16H2,1-3H3;6-13,17,32H,14-15H2,1-5H3/t19?,24-;;2*18?,22-;/m0.10./s1 |
| InChIKey | BVXZRLDRIPLLND-OAQIQQINSA-N |
| XLogP | 18.13 |
| TPSA | 444.20 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 184 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2514.89 |
| LogP ≤ 5 | 18.13 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 40 |